{
  "symbol": "BMRN",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "focus on rare diseases", "clinical trial developments"],
    "riskScore": 7,
    "reason": "BioMarin operates in the biotech sector, which is prone to speculation, especially due to its focus on rare diseases and ongoing clinical trials."
  }
}